Author: Altundag Ozden Dursun Polat Ayhan Ali
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.15, Iss.4, 2010-12, pp. : 557-568
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. :
Emerging drugs for focal epilepsy
By Mula Marco
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. :
Emerging drugs for neuroblastoma
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. :
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. :
Emerging drugs for ophthalmic diseases
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. :